干细胞之家 - 中国干细胞行业门户第一站

标题: 干细胞移植常用生物学词汇 [打印本页]

作者: fellc    时间: 2008-12-27 14:20     标题: 干细胞移植常用生物学词汇

2,3-DPG:2,3-diphosphatidylglyceric acid,2,3-二磷酸甘油酸" }- E6 ^4 o  e: i
2-CdA:2-chlorodeoxyadenosin,cladribine,2-氯去氧腺苷& D  _" }; g5 O, I5 v/ u
3H-TdR:tritiated thymide,氚标记胸腺嘧啶核苷
$ [- v' B  Z0 e4 n* V. V5-Aza:5-azacytidine,5-氮(杂)胞苷
  q" Z0 P! V6 E: T5 Ja2-PI:a2-antiplasmin, a2-纤溶酶原抑制物
4 L. U: {8 ^' w2 q. @& rAA:aplastic anemia,再生障碍性贫血
0 a2 x! w9 m' uAAV:adeno-associated virus,腺病毒相关病毒3 M  _+ e4 k* C  o5 d0 T8 M8 Y1 ~
Ab:antibody,抗体) w$ `/ m7 W. Q6 ^1 |% {4 a
ABC:avidin-biiotin complex method, 亲和素生物素复合物法( e% B/ d3 y  W' d! \( n. J
ABMT:autologous bone marrow transplant,自体骨髓移植1 c2 E8 T4 \1 U1 [1 X- w
Ac:accessory cell,辅佐细胞8 |: m* P0 ]' g1 m
ACD:acid citrate dextrose,酸性枸橼酸盐葡萄糖
0 j$ x4 C  d" }% K5 ^  CACP:acid phosphatase,酸性磷酸梅
5 }- Q- x2 ^& S) \ACTD:actinomycin D,放线菌素D  e" C/ W2 b( n% I$ e  F7 D' w
Acute:急性的
4 V3 L9 f9 ?& O4 tACV:cyclovir,阿昔洛韦/ t  X5 y5 X0 J0 J( j# G
Ad:adenovirus,腺病毒
! T, O! {6 e. }1 c8 k( HAD:antigen determinant,抗原决定簇
; ~" b  E& {: O  J3 a; ]ADA:adenosine deaminase,腺苷脱氨酶& Y9 c. P5 h% J) Y
ADCC:antibody-dependent cell-mediated cytotoxicity)抗体依赖细胞介导性细胞毒性1 G+ x' s/ J+ S
Adjuvant therapy:辅助治疗& |6 h8 F* J9 g( l1 s. u  k
AEL:acute erythrocytic leukemia,急性红白血病5 A/ d# B' d7 m6 U$ N
AEoL:acute eosinophilic leukemia,急性嗜酸粒细胞白血病
  t( m- N# {. `AFP:alpha fetoprotein,甲胎蛋白- E5 R- k3 @- w" k' b7 Q
Ag:antigen,抗原+ h6 @0 r/ q  E/ s
aGVHD:acute graft versus host disease,急性移植物抗宿主病
: v- e: g; f- S% G- ]Aid:anti-idiotype antibody,抗独特型抗体
. L! v3 O0 D. X- n7 {AidS:acquired immune deficiency syndrome,获得性免疫缺陷综合征4 n; v) d' d  Q4 t& _, p9 c0 |
AIF:apoptosis-inducing factor,凋亡诱导因子
" {: c7 d5 A5 T  m& o" m9 AAIHA:autoimmune hemolytic anemia,自身免疫性溶血性贫血* o$ J7 |2 O4 j( P8 D
AL:acute leukemia, 急性白血病# S$ h+ |4 M' f6 D+ K5 t+ P9 l
ALCL:anaplastic large cell lymphoma,退行性大细胞淋巴瘤
9 @& C( A. o8 ^+ S" RALG:antilymphocyte globulin, 抗淋巴细胞球蛋白1 a( E6 T- ^- U  G  {
ALIP:abnormal localization of immature precursor,未成熟前体细胞异常定位
. M2 I. d% w% u4 T2 y9 Z1 yALL:acute lymphocytic leukemia,急性淋巴细胞白血病
8 |* j$ g% `5 M9 [4 L* ]  BAllo-BMT:allogeneic bone marrow transplantation,异基因骨髓移植
+ E4 K7 G# @* z# d% EAllo-PBSCT:allogeneic peripheral blood stem cell transplantation,异基因外周血干细胞移植
: E% V5 U" N$ H" X, ]Allogeneic:异基因的 : M$ {- W7 I' }
Allograft:异体移植物
4 M/ \; g; c) eAlopecia:脱发
; e* {, L( C  E/ t( d6 _" dALP(AKP):Alkaline phosphatase,碱性磷酸酶' a9 Y8 ~0 x1 y3 U/ v+ |8 F$ B
AM:adhesion molecule,粘附分子
( w4 A7 K" v) S5 }! e3 K8 qAMKL:acute megakaryoblastic leukemia,急性巨核细胞白血病3 ~4 Z) M0 l0 B+ t4 P. z
AML:acute myeloid leukemia,急性髓性白血病
, _( ]6 q5 Y: a7 Y6 _AMM:agnogenic myeloid metaplasia,特发性髓外化生
" E, `* }! D4 sANA:antinuclear antibody,抗核抗体
1 w( e. L) I+ o( l- \Ana-LL:anaplastic large cell lymphoma,大细胞淋巴瘤
: R! d0 m- r7 @7 HAnaphylaxis:过敏症; P! B/ O) J- Y8 X0 l% [: W1 E

7 B/ j# A5 n: J  GANC:absolute neutrophil count,中性粒细胞绝对值6 O& s* n0 i' Z5 y) l5 ~* F
Anemia:贫血8 L6 R8 X6 T/ X2 @' v- Y
ANLL:acute non-lymphocytic leukemia,急性非淋巴细胞性白血病
- {$ l+ A) @; P$ q; n) ^8 I* c  }! hAntibiotic:抗生素;抗生的
* d6 X0 N5 }6 Z' [+ v! s7 ?Antiemetic:止吐剂,止吐药
' @3 i+ P: Z; kantineoplastic drugs:抗肿瘤药物/ p. [! s# y! V7 ]3 J0 ~
Antisense:反义引物9 k5 C) v' ^! ^4 G( L; a+ W
APBSCT:autologous peripheral blood stem cell transplantation,自体外周血干细胞移植5 b6 @" u) k. B
APC:antigen processing cell,抗原呈递细胞5 X. j( P/ h, ?. \
Apheresis:血浆分离置换法,血液成分部分清除
( K  g( I+ l6 A$ b0 Z1 E* eAPL:acute promyelocytic leukemia,急性早幼粒细胞白血病
* @2 Z* |& b' G0 N9 r3 A7 o# tAplasia:发育不良,成形不完全
( ~' W" L  r* R! X* v- `Apoptosis:凋亡! H1 d" \# H. Q2 q  C5 \3 _
Ara-C:arabinosyl cytosine,aracytidine阿糖胞苷
" ^" c; J+ ~, CARDS:acute respiratory distress syndrome,急性呼吸窘迫综合症;AidS-related diseases艾滋病相关疾病- J  J4 c; u% i! t' h) s, Z. G
Ascites:腹水
5 k/ l6 g: c2 s$ i& iASCT:autologous stem cell transplantation,自体干细胞移植; L4 z. l1 U: ~5 e- \
Aspergillus:曲霉属5 [* ]. B0 n0 b1 Z0 I
ASS:anterior superior spine,髂前上棘
2 K/ L: k2 D8 D6 |  b9 ]+ YAT1257:nitrocaphane,消瘤芥3 Q8 u) w  q0 U8 A+ `. N2 W. ]
ATG:antithymocyte globulin,抗胸腺细胞球蛋白1 |4 h& L: u- `! Z# g
ATL:adult T cell leukemia/lymphoma,成人T细胞白血病/淋巴瘤* K/ y7 Y3 ?4 P. L
ATLS:acute tumor lysis syndrome,急性肿瘤溶解综合征
( ?7 e, j- Y' o' W0 ?4 n  WATRA:all-transretinoic acid,全反式维甲酸3 x, d9 A& h3 f
AUL:acute undifferentiated cell leukemia,急性未分化细胞白血病
. j, ?8 p8 c" }AuSCT: autologous stem cell transplantation,自体造血干细胞移植
# R" u9 j9 b( ~1 i& k4 qAutologous:自体的
. ~/ o; n& P( t8 }; {9 _8 wAutograft:自体移植物 + r0 Y: V* X5 o
Auto-BMT: autologous bone marrow transplantation,自体骨髓移植
$ V) c- M+ e0 l' M. H7 pβ2-MG:β2-microglobulin,β2-微球蛋白) q/ S1 e$ J$ Z9 ^
Back-up:备份
) O9 l8 x. e0 CBCNU:Carmustine,卡氮芥,卡莫司汀1 B/ |7 V+ l: T  h$ w1 Q; A4 r
BCR:breakpoint cluster region,断裂点丛集区
* }0 r1 a! w, y* }, N: F' ^7 JBFU-E: burst-forming unit-erythroid,早期红系集落生成细胞# w/ i' I/ i( ]1 ]' `* r9 X
Biopsy:活检
, F9 _* {  C9 N9 qBlast cell:原始血细胞,母细胞
/ G- M& {6 H- F7 }1 [Blast-CFC:blast colony forming cell,原始细胞集落形成细胞
2 D( r, y" [7 H) ?+ d& RBlast crisis:原始细胞危象 6 ]8 M" S7 Y" J: }+ N: H- e
Bm:memory B lymphocyte,记忆B淋巴细胞
$ h7 \4 f% m. v" ]2 R/ P5 U. p/ uBMG:benign monoclonal gammopathies,良性单克隆丙球蛋白病: a7 L, |0 B* h! [7 M; }6 r% G
BMT:bone marrow transplantation,骨髓移植) e/ y) H; `5 T, d
Bone marrow biopsy:骨髓活检+ c1 T1 `/ Y0 `
Bone marrow puncture:骨髓穿刺2 h; E* C( y* s% z% E+ ~2 m- x/ K2 _
Bone marrow smear:骨髓穿刺涂片
1 o* X; [9 `0 E$ k' cBRM:biological response modifier,生物应答调节剂7 C4 L8 [5 W) _  H
Bu:busulfan,白消安,马利兰
9 z% ^3 U- a* L! c$ C+ e) y& WBuffer:缓冲,缓冲剂,缓冲液
6 d$ T5 \% O+ O+ y& Q* u  A  [; jCALLA:common acute lymphocytic leukemia antigen,普通急性淋巴细胞白血病抗原  ~! |) H: b$ M
CAM:cell adhesion molecule,细胞粘附分子+ y6 f# e" V; u  F6 F$ q6 W
Candida:念珠菌属,假丝酵母属
( M& H/ b( d& T3 L( ~' Q; TCatheter:导管 1 o! J' t, S9 v8 i+ Z
CB:cord blood,脐带血$ e9 Z# u1 N5 j: ?
CB1348:chlorambucil:苯丁酸氮芥
+ V2 C! ^5 P+ H$ KCBC:complete blood count,全血细胞计数   J. q/ l7 K+ d; ?, ^3 s7 d- B
CBCL:cutaneous B-cell lymphoma,皮肤B细胞淋巴瘤" @- P5 o- `8 V0 a
CBSCT:cord blood stem cell transplantation,脐血干细胞移植
: l$ P- i! [& H( SCCI:corrected count increment,校正增值计数% w9 v' n( q1 t7 j3 Q
CCNSA:cell cycle non-specific agents,细胞周期非特异性药物
8 z% b6 X3 Y$ H. HCCNU:lomustine,洛莫司汀,环己亚硝脲
0 ?9 v% s* _% u5 oCCR:continuous complete remission,持续完全缓解
6 D. |0 A" U& VCCSA:cell cycle specific agents,细胞周期特异性药物: @4 h; Q! f( s
CD:Castleman's disease,Castleman病
, g0 e) e0 o' Q( cCD:cluster of differentiation,分化群
0 P5 w! [6 R6 z+ r% jCD3AK:CD3 activated killer,CD3激活的杀伤细胞  n* \+ {/ ^: L3 q' A' }
CDK:cyclin dependent protein kinase,周期素依赖蛋白激酶' ~6 a! L5 h' e' d% q
CEA:carcinoembryonic antigen,癌胚抗原
6 }9 B3 \! [. q" J; gCEL:chronic eosinophil leukemia,慢性嗜酸性粒细胞白血病
! I; a- J/ G8 n' P  \0 I( O6 `( PCentral line:中心静脉导管,见central venous catheter. , ]( k3 S. b# a2 W
Central venous catheter: 中心静脉导管,又叫做central line,Hickman catheter - ~! p" k# W& k0 |
Centrifugation:离心7 M, ~' f& b0 y# x1 m/ }, L. v
CFC:colony-forming cell,克隆形成细胞/ ]0 ]0 r( j1 X2 a$ ?0 w6 t
CFU:colony-forming unit,集落形成单位
2 A2 ]+ W7 s' X, UCFU-Blast:colony-forming unit-Blast,原始集落生成细胞4 Q" n+ j: l4 W5 P6 M
CFU-E:colony-forming unit-erythroid,红系集落生成细胞
& o! P( D4 ~" a+ R: f) u- iCFU-G:colony-forming unit-granulocyte,粒系集落生成细胞2 R; U2 V0 S" o6 N
CFU-GM:colony-forming unit-granulocyte/macrophage,粒单系集落生成细胞1 W9 X# M3 V9 @1 q& h
CFU-L:colony-forming unit-leukemia,白血病细胞集落生成单位9 M) F! }3 x. k' G% f+ i1 G7 z
CFU-MEG:colony-forming unit-megakaryocyte巨核系集落生成细胞
6 Q. b/ j6 H3 {2 P" Y- ^6 r9 A: jCGD:chronic granulomatous disease,慢性肉芽肿病
$ q* N, p% i6 P& C5 N) _5 cCGP:circulating granulocyte pool,循环粒细胞池
4 U7 r' h7 V- e/ T2 c* fcGVHD:chronic graft versus host disease,慢性移植物抗宿主病
! b5 C5 P4 N6 C% VChemo-responsive:化疗敏感的 , `+ x2 M5 s, A9 S4 T% r- @2 \
Chemotherapy:化学疗法
% }: y* s  ]  @! e' mChronic慢性的   ?; [/ Y7 ]) z3 K1 c( X  J
C.I.:continuous infusion,持续静脉点滴
, r7 ?& k, B% Y6 G# |CIK:cytokine-induced killer cells 细胞因子诱导的杀伤细胞( E( B  ^& ~0 W" y' ^$ k! ]% u
CliniMACS:clinical magnetic activated cell sorting,临床级磁性活化细胞分选系统8 l: Q" l  U+ h" h7 f0 K0 D
CLL:chronic lymphocytic leukemia,慢性淋巴细胞白血病
6 {  `9 H& R9 M  JCML:chronic myelogenous leukemia,慢性粒细胞白血病
7 F9 o4 Z( Q! l5 D- X, I( }4 uCML-AP:CML-accelerated phase,慢性粒细胞白血病加速期/ }9 l9 @' |" X" W0 P9 C. P$ e
CML-BP:CML-blastic phase,慢性粒细胞白血病急变期+ A. ~7 ^. n7 O0 Y4 D; t
CML-CP:CML-chronic phase,慢性粒细胞白血病慢性期
( y6 Y" c  k" k# YCMML:chronic myelo-monocytic leukemia,慢性粒-单细胞白血病% _7 q+ H% l) m% t. W+ t' a
CMPD:chronic myeloproliferative disease,慢性骨髓增生性疾病
3 z' a7 v9 G* o8 |1 v0 U/ @/ `- \CMV:cytomegalovirus,巨细胞病毒
2 x' u/ ^5 y0 ZCNR:cytokine negative response cell,细胞因子不反应细胞( ^1 d/ x# H7 |+ o
CNS:central nervous system,中枢神经系统* O6 B; Y* U" u1 R/ \: g& z/ b
CNSL:central nervous system leukemia,中枢神经系统白血病0 U) r; d6 D% U* M
Collection: 采集
" o. f$ G! t/ LColony stimulating factor:集落刺激因子 # t9 O6 \8 h! k
c-onc:cellular oncogene,细胞癌基因( d$ `+ S7 n! w% W& ?$ i
Conditioning:预处理
5 N( K) I$ |1 A' ?7 pConjunctivitis:结膜炎
# j, [1 }& l+ Q5 r3 CConvalescence:恢复,恢复期- w* a" u. {8 I' S' R
CP:cancer procoagulant,癌性促凝物质8 _7 m/ Y1 t. D8 a
CPD:citrate phosphate dextrose,枸橼酸盐-磷酸盐-葡萄糖9 _9 J2 X5 B! R! K' ]( n4 [& x
CPDA: citrate phosphate dextrose adenine,枸橼酸盐-磷酸盐-葡萄糖-腺嘌呤
$ O" A7 M, n* M7 n* S0 hCpmax:peak concentration,峰浓度/ p& L! O( ?# i' Q% y
CPT:camptothecine,喜树碱: c4 g2 E; P% m7 Q
CR:complete remission,完全缓解
5 J6 A+ {7 j. [; T0 l0 f1 }1 f+ E% ACRABP:cytoplasmic retinoic acid binding protein,胞浆维甲酸结合蛋白( I' Z" V/ ?; K0 U
CRP:C reaction protein,丙反应蛋白 2 x2 z3 o! g1 C: m1 J3 g
CRR:complete remission rate,完全缓解率
1 z5 p9 ?9 u# f; FCryopreservation:冷冻保存,深低温保藏 # U4 w0 Q7 z1 Q5 U% `
CSF:colony stimulating factor,集落刺激因子
8 f$ C9 D' i9 E9 T2 w: C/ D# rCSF:cerebrospinal fluid,脑脊液
8 o8 g; j$ x; L" ~. Y' P2 ZCTCL:cutaneous T cell lymphoma,皮肤T细胞淋巴瘤
$ Q' ~* [8 ]4 k; n# C3 H; k, ]% rCTCL:central T cell lymphoma,中枢T细胞淋巴瘤
& m' X7 X8 m  r: ]CTL:cytotoxicity T lymphocyte,细胞毒性T淋巴细胞/ e. w" V/ q3 r7 d8 N  D7 v
Cyclin:周期素
* K0 Q5 a1 o/ q6 pCytomegalovirus:巨细胞病毒 ' e4 {+ U3 j: w+ ]& h+ z5 i! y4 H
DC:dendric cell,树突细胞: d/ k# p9 a; F9 ~/ |# T& N: [% k/ s
D-D:D dimer,D-二聚体
0 a9 h0 J% t8 j* I+ b  nDel:deletion,缺失0 `; `6 u: `4 h7 y  L
Dermatitis:皮炎
( R. D0 G+ g: D/ KDe nova AML:非继发性急性髓性白血病 & B$ }) y% i; d; q
DFS:disease free survival,无病生存期% p, s) f/ n; M$ N( V/ g+ L
DI:DNA index,DNA 指数5 P  Y' \$ Q. K9 l) s9 L8 k" K
DIC:disseminated intravascular coagulation,播散性血管内凝血
9 Q' Z3 r! E6 H- F$ _% TDilution:稀释8 W, Y" v  k# Z$ C0 D
DL:discordant lymphoma,混杂型淋巴瘤8 M8 @9 v9 L6 C4 P+ q9 Y7 Y
Donor:供者. y! R- ]) X  @
Dysplasia:发育不良,发育异常 ) O& R. z; U+ L" ^& Y0 |9 F
EBV:Epstein-Barr virus,EB病毒$ Z% u3 p* V* H* d" U, D8 I% Y3 n1 @
ECM:extracellular matrix,细胞外基质
* }4 n& W7 ?) K+ e' v6 \-ectomy:(后缀)(外科)切除,除去,去掉
* }) I% k* L" y6 e, oEdema:水肿
: T7 o9 G. G/ x0 |( A& e8 t( l# LEGF:epithelial growth factor,表皮生长因子
8 V9 x7 m4 ?' g& M! q-emia:(后缀)血液疾病
, q! a! A; {2 l, y4 f) a) y7 HEncephalopathy:脑病
, _, u6 P/ s1 f6 l2 |8 {* QEncode: 编码
4 |9 o" m2 o! @# o8 P. W& IEngraftment:移植物植入 % k7 k9 n3 {/ Y, H  n% i& N% r
Enrich:富集: V0 \& x7 l- A  u
Enzyme:酶
  c. G' \7 D1 f" @  F  e" p8 bEosinophil:嗜酸性粒细胞: t* v+ _8 N7 b: g
EPO:erythropoietin,促红素,红细胞生成素& n: e2 F. P8 q  w8 \
ETT:essential thrombocythemia,原发性血小板增多症8 l8 F4 o1 u( l3 R# V! y: _
Ex vivo:体外
, l( d- r$ b. U5 G+ R' m  {  I: d$ BFACS:fluorescence activated cell sorting,荧光活化细胞分选系统
% `4 _+ N1 q) }2 p0 N& L3 zFCM:flow cytometry,流式细胞分析技术" Z7 l( E+ }7 }3 C' }5 [
FDC:follicular dendritic cells,滤泡树突状细胞  i3 w4 q. v7 j& y9 J
FDGF:fibroblast derived growth factor,成纤维细胞源生长因子 2 K: o; A" k0 x) h. N2 [, ^( Q
Febrile:发热的
: I' e, h% h; W, L8 {FFP:fresh frozen plasma,新鲜冰冻血浆
) J/ Z8 e# W1 ~* y) @& ]/ P/ jFGF:fibroblast growth factor,成纤维细胞生长因子
* M$ U0 m% C  r7 e* ?7 i1 t# OFHH:familial hemophagocytic histiocytosis,家族性嗜血组织细胞增生症  s9 Q+ x( K7 H0 F4 X
FISH:fluorescence in situ hybridization,荧光原位杂交
# A6 {; T' ?( h( v$ m! P' m- P. o1 ZFMF:familial Mediteranean fever,家族性地中海热  u3 C+ W2 X% g& d% G& o
Foley catheter:弗利氏导尿管,气囊导尿管 % z3 o, a! q# d5 A+ K# j/ v
FrTBI:fractional total body irradiation,分次全身照射
7 y7 y5 B+ h) m: P5 u9 r+ V8 jFSRC: 胎羊体内增殖的人造血干细胞, a% f; ]0 M. g2 q# ~
Fungus:真菌 ) i6 w7 w/ W; {% N. F
Fungi: Fungus复数形式
9 k5 U- `! {0 t6 L3 zG6PD:glucise-6-phosphate dehydrogenase,6-磷酸葡萄糖脱氢酶
, e6 J0 S( D. u& V$ rGastritis:胃炎
% F& s6 \# U& a# d1 @4 d8 f  }Gastrointestinal:胃肠道的 # H& i0 Q7 n3 b- f: d
G-CFC:granulocyte colony forming cells,粒细胞集落形成细胞$ i- @' F& B' z2 g
G-CSF:granulocyte colony stimulating factor,粒细胞集落刺激因子
5 m, v) q2 W- R' FGCV:cytomegalovirus,巨细胞病毒! i9 @, d7 x, G  S& ~- L
GCV:ganciclovir,更昔洛韦
) y: m; O+ D+ ]: b: j# LGI:gastrointestinal,胃肠道的. Q) ~* v: a- T% N
GM-CSF:granulocyte-macrophage colony stimulating factor,粒-巨噬细胞集落刺激因子 6 ^) V- d7 y* _! J
GM-CFC:granulocyte-macrophage colony forming cells,粒-巨噬细胞集落形成细胞
, Z' r* X8 R2 R& @+ s) @Graft rejection:移植排斥(反应) $ I+ t9 g% x! F4 K1 M2 L( i' |$ Y
Graft-versus-host disease:移植物抗宿主病 8 x/ \8 K" V7 J. |" ~1 s
Granulocyte:粒细胞
3 i; b3 j! T, l! ^; ~5 ]Growth factor:生长因子 5 [: L8 R+ H: D  k7 M
GTR:granulocyte turnover rate,粒细胞转换率
4 w& m$ b4 ^6 |% bGVHD:graft-versus-host disease,移植物抗宿主病
* a- w  W: b; u! yGVHR: graft-versus-host reaction,移植物抗宿主反应
% ?, @0 {7 A& L' QGVL:graft-versus-leukemia,移植物抗白血病) H' [' N" w# q) Y3 V
GVT:graft-versus-tumor,移植物抗肿瘤# Y; K; N2 d% E) g
Haploidentical: 半相和的  A2 e( r4 {3 R# ]+ d0 \
Harvest: 收集,采集- m- ]% T3 }1 y
HC:hemorrhagic cystitis,出血性膀胱炎9 k- _. n9 _: h" r8 ?( h; v  `
HCL:hairy cell leukemia,毛细胞白血病
# o: f* i- K1 v4 G+ I" L1 s& L3 UHD:Hodgkin's disease,霍奇金病
* [7 j# p; H& |1 ~* xHD:high dose,大剂量
* N' K# h4 }0 D: wHematocrit:红细胞压积 ! p# b$ v) W( W2 p/ u
Hematology:血液学
8 R4 \6 d9 l- b$ ~$ {) \) p% VHematopoiesis:造血作用,生血作用2 D3 y! V7 @: K+ Y& k% `
Hematopoietic system:造血系统
1 ~2 ], \/ ]/ K5 D; xHemoglobin:血色素,血红蛋白
- i. J; l5 J, X" w7 ~3 ?7 c& p# ZHemorrhage:出血 ( j$ q1 G- ^, b9 z
Hemorrhagic cystitis:出血性膀胱炎
8 {9 R/ M! Z% b0 j# w- M; uHepat - :(前缀)肝的2 N2 n) Q: v2 ?; o' r& H9 w: k
Hepatitis:肝炎
: @& Y$ _& b  e1 K8 D# q# Z6 z/ rHES:hypereosinophilic syndrome,高嗜酸粒细胞综合征
: }9 B1 t/ Q" H& t. EHGF:hematopoietic growth factor,造血生长因子9 |% t4 p  y+ X/ j5 V1 t) H! J) f
HHV:human herpus virus,人疱疹病毒
( F9 w) ~8 f# p: j" L1 n  h  Z  X' NHickman catheter:Hichman导管,中心静脉插管 : e2 H7 c. o  e& c* P
HIV:human immune deficiency virus,人免疫缺陷病毒- i1 a6 O5 f7 G4 ]4 q# d/ k
HLA:human leukocyte antigen,人类白细胞抗原 " r7 h9 [" O  a+ W( X( K, X
HLH:hemophagocytic lymphohistiocytosis,嗜血细胞性淋巴组织细胞增生症
) g% _! d2 m, _HMR:histiocytic medullary reticulosis,组织细胞性髓性网状细胞增生症$ R0 v3 d/ v$ U
Homogenic transplantation:同基因移植* d6 p8 i/ ]5 `4 _( K' T6 m" ^
Homozygote:纯合子
0 ^- J. N/ h* AHPC:hematopoietic progenitor cell,造血祖细胞5 {" X# c1 n+ ~- u
HPP-CFU:high proliferative potential colony-forming unit,高增殖潜能集落形成单位% N2 [' q0 g7 A* |& W: V  F2 P
HR-ALL:high risk ALL,高危型急性淋巴细胞白血病! L" u$ ]9 H( A7 l- ?
HSC:Hand-Schuller-Christian disease,韩-薛-柯病
( v$ H  |3 Z  K( U  T0 _! }* kHSC:hematopoietic stem cell,造血干细胞
) `5 B0 K- K' }+ C5 E% RHSR:homogenously staining region,均染色区* g. c6 Z9 U7 Y$ l! \
HSV:herpes simplex virus,单纯疱疹病毒' U7 K. M) K3 S
HTC: typing cell,纯合子分型细胞. m; A% B# O* x  [8 {5 ^
HTLV:human T cell leukemia virus,人类T细胞白血病病毒
( _; B4 y. ]( T/ ~0 R: `" _4 x/ BHVOD:hepatic venous occlusive disease,肝静脉闭塞病
/ B; g& l4 z' \: C  VHyper- :(前缀)高,超,(过)多
7 Z' ^$ ^* n* [9 S: d% p* v6 Q6 {Hyperalimentation:高营养支持,静脉高营养" z( ^" ^' L3 c. `% x; \
Hyperpigmentation:色素沉着过度 $ u; q5 F7 c3 z2 w, |
Hypertension:高血压 3 ]+ @6 X! I6 P( g; R
Hypo- :(前缀)(过)低,少于/ Z$ X3 X4 Q- V' H; [% W- t
Hypotension:低血压
7 b4 c. ?! a5 d) \  fIAHS: infectous-associated hemophagocytic syndrome,感染相关嗜血细胞综合征
" x1 ^* }, l; ?& j) v& aid:medium dose,中剂量! o3 p. {0 p: P
id:initial dose,初始剂量  l  \8 K7 I) |# U) U
IF:involved field,累及野
8 u& p9 w7 E7 `: y  ?$ K* N" J8 jIFN:interferon,干扰素
' X- P' P6 M; ]9 A# {, fIg:immunoglobulin,免疫球蛋白
  a: }+ K3 w+ L: {1 g: S  \IGFs: insulin-like growth factor,胰岛素样生长因子2 I! p- w/ k7 O/ ^8 L9 N* H
IgH:immunoglobulin heavy chain,免疫球蛋白重链
: w* e0 K0 G; d! xIL:interleukin,白细胞介素
1 d6 \1 m* F, b" b( F3 z2 |Iliac crest:髂嵴
, @7 d: @+ s  u% S6 ]I.M.:intramuscular,肌肉注射
+ K: G% ^# C- j. _) `2 H# [Immune system:免疫系统 ! o4 b% C0 R0 f
Immunocompromised:免疫受损的
0 Q0 G! |" A- p2 A# l4 J0 gImmunoglobulin:免疫球蛋白 - I4 K7 Z: W& K, j
Immunological tolerance:免疫耐受+ ^: E! l2 G3 t! j, F
Immunosuppression:免疫抑制 5 b- |! A4 C  W9 i" j- k! U
Incubation:孵育$ L2 Q0 m! A9 G
informed-consent:知情同意
7 h, e& U8 d5 i$ U' B" m+ tIntravenous:静脉内的
& H& k0 s4 ~% m* Minv: inversion,倒位" r5 R  K9 j6 r4 ~' c/ o( ?. T
in vitro: 体外,离体
" b8 o3 a: y1 v( G/ l) jin vivo: 体内
" B/ R  O4 D  fIP:interstitial pneumonia,间质性肺炎
. v9 k" G1 H4 ~  ?Isolation: 分离
' H  D) c# z  l) WI.T.:intrathecal injection,鞘内注射" L! l9 N: L" z8 \1 l
-itis:(后缀)炎症
- l& R0 o/ ^8 q5 f9 Z2 kITP:idiopathic thrombocytopenia purpura,特发性血小板减少性紫癜
0 L/ ~6 y# J: {Jaundice:黄疸  c% J7 v7 v4 Z
KPS:Karnofsky score, Karnofsky评分
; Z, F* x2 @2 Z* [& B; jLAK:lymphokine-activated killer(cells),淋巴因子激活杀伤(细胞)2 K+ q: \% k1 N
Laminar air flow unit:层流间 7 ~0 j/ [$ _* G0 m3 D1 ~
LCH:Langerhans cell histiocytosis,郎格罕细胞(组织细胞)增生症* z  Q. r# y+ l. U1 N1 {
LD:lymphocyte depletion,淋巴细胞消减型) x1 V7 X- J3 O9 \! G% A' h
LD:low dose,小剂量8 `: d' D' Y" _
LDH:lactate dehydrogenase,乳酸脱氢酶
# ^6 R9 s% J/ p* P5 m. O6 ?$ WLeukapheresis: 白细胞采集物
0 X! [- x  n8 f9 sLeukemia:白血病 2 Q) b  b) \0 z* I" q/ T; M2 w
Leukocyte:白细胞
8 ^0 K9 a$ D- S  y. ~; WLeukopenia: 白细胞减少症/ r( \7 f" J' p! w: _+ `) I
LFA:lymphocyte function associated antigen,淋巴细胞功能相关抗原
" }* A# N5 J% X& B  e) ~* TLFS:leukemia free survival,无白血病存活期
& q( O5 A% d4 y+ b* Z/ zLGL:low grade lymphoma,低度恶性淋巴瘤8 a% ]9 k3 J$ N& s( R1 U0 t) e; n
LHR:lymphocytic homing function receptor, 淋巴细胞归家功能受体3 ]# a" s$ a) d7 E; K9 ]: j
LI:labeling index,标记指数
. `5 ?& _+ \. A) S( zLIF:leukemia inhibition factor,白血病抑制因子
  L$ n4 A5 a5 Q% |9 w/ t3 MLineage:系9 \5 u" A1 ^  a! Z  m5 F+ n/ `
LOH:loss of heterozygosity,杂合性丢失- h5 h8 Z  e8 U% E3 L* @# S
LP:lymphocyte predominance,淋巴细胞为主型3 l3 ?. N% d0 B/ U
LRP:lung resistance related protein,肺抗性相关蛋白
. T6 B( ?: u$ z, b: F+ \LTB:life-threatening bleeding,致命性出血" h( V6 A* t' @& V& e
LTC-IC:long-term culture-initiating cell,长期培养起始细胞
. y# ~9 P3 q; W+ z% B+ P* j2 FLTR:long terminal repeat:长末端重复序列+ E( q" M" }& O* ~
LVL:large volume leukapheresis,大容量白细胞单采
8 h( h  d+ Y6 ?& ~9 JLymphocyte: 淋巴细胞
/ `, d) y6 x' J6 v! @# a8 E7 AMacrophage:巨噬细胞
9 l8 T* {9 [3 v" r5 y* P- L+ K' nMACS:magnetic activated cell sorting,磁性活化细胞分选
9 E4 n/ O; m& G1 }& j( @MAK: monocytokine-activated killer(cells),单核细胞因子激活杀伤(细胞), g% l! b$ @! f0 d* l$ f- I7 ^; z
Malabsorption:吸收障碍
2 [" Q# ~3 j  \) E/ m! fMALT:mucosa-associated lymphoid tissue,粘膜相关淋巴样组织÷
' p" g# S# |- F+ x* b5 BMatching:配型7 \3 [5 f4 b  M  K! G
MBDI:marrow blast decline index骨髓原始细胞减少指数
2 O8 b# R* g; z4 a6 A& `MC:mixed cellularity,混合细胞型3 W2 z$ R) _$ [# z$ `
McAb:monoclonal antibody,单克隆抗体4 o- l+ x( F/ ^, t
mCR: median complete remission,中位完全缓解
/ j! D3 ]% L7 b3 e! O0 i4 q8 x; BMDR:multiple drug resistance,多药耐药
3 H' t# }# K8 EMDS:myelodysplastic syndrome,骨髓增生异常综合征
' M( F* ^6 V/ X' B/ L, QMegakaryocyte:巨核细胞
- ?$ |( R/ s5 B" ]& q! ]) FMetabolite:代谢物 ; b0 [) }6 }: M
Metastatic:转移的 2 \( Y/ \$ m  ]  e0 @( X4 P
MF:myelofibrosis,骨髓纤维化
- l9 C; h4 d9 ]+ s$ I' J" ], nMF:mycosis fungoides,蕈样霉菌病
0 \! k" E2 w, U  q  C+ zMGDS:megakaryocyte growth and differentiation factor,巨核细胞增殖分化因子
9 k+ E0 Z4 S8 W) J' @# w& @MGP:marginal granulocyte pool,边缘粒细胞池& }0 g; u$ |* H: ]
MGUS: monoclonal gammopathy of undetermined significance,未定性的单克隆γ球蛋白血症' M2 Q, @/ D+ W# V# [7 \2 s
MH:malignant histocytosis,恶性组织细胞增生症
) Z8 g8 Q8 c9 ^! g+ j+ f9 T7 P9 ^: Q3 G; rMHAS:minor histocompatibility antigen systems,次要组织相容性抗原系统
. `( [& {6 R, L; W9 j! k2 BMHC:major histocompatibility complex,主要组织相容性抗原复合体$ F+ y1 L9 B& d! B4 S
MLC:mixed lymphocyte culture,混合淋巴细胞培养
  M; v+ J( w6 y9 G  NMLL:mixed lineage leukemia,混合系白血病
" I9 W: L6 ]9 }2 D8 V( N4 ?MM:multiple myeloma,多发性骨髓瘤: o  `/ p8 R$ c* s( j
MNC:mononuclear cells,单个核细胞
+ [' w8 i# i! E2 cMobilization:动员
+ Z- A7 n$ {+ p5 ~Monoclonal antibody:单克隆抗体 0 s1 E, j: V2 `0 f; S8 k0 L8 Q
Monocyte:单核细胞
9 C, q* ~  p) {9 O4 v; BMonozygotic:单合子的7 B/ n# F% I- `& l, d
Morbidity:发病率
$ e" G* ^' z& t% ~6 fMPD:myeloproliferative disease, 骨髓增殖性疾病9 i2 E- @. w! W3 p  F
MPO:myeloperoxidase,髓过氧化物酶
: k- L0 {6 ^* e/ |MRD:minimal residual disease,微小残留病变
5 F5 {9 c  }3 a$ LMRP:multidrug resistance-associated protein,多药耐药相关蛋白; o! S& H# M" O) v
Mucositis:粘膜炎
; `2 F' k9 T5 X# [7 B1 f7 s% o0 qMUD:matched unrelated donor,非血缘关系配型相合供体. N, w, K9 V6 q9 V- z
NAP:neutrophil alkaline phosphatase,中性粒细胞碱性磷酸酶. v: Q: T( ^" G- m; e: ^' E5 X
NB:neuroblastoma,神经母细胞瘤0 ^' j: h% w5 s
NBM:normal bone marrow,正常骨髓3 b* F$ f' I9 {; W
Negative selection:阴性选择, h1 M! H3 [& e1 |6 d; x8 T
Neuro- :(前缀)神经的
" b/ @6 N) {6 H, \1 ENeutropenia:中性粒细胞减少症 * c9 c" c, M9 I0 N! Z
Neutrophil:中性粒细胞
8 A/ G0 [0 V7 O  H. [NG:neutrophil granulocyte,中性粒细胞9 ]7 N$ n1 Z/ a! B. s' K# O# A+ H
NGF:nerve growth factor, 神经生长因子- L. ^2 G  y2 R3 l+ w2 u
NHL:non-Hodgkin's lymphoma,非霍奇金淋巴瘤
+ N4 @! ~: {+ F. F) O! C7 NNK: nature killer cell,自然杀伤细胞( {, N9 \( g3 y& h0 \: v
Nonmyeloablative transplantation: 非清髓性移植
  I9 Y) s. |* j2 y6 y7 P8 ]NPO:不能进食 ) Q# l: Z, |: M: e" u3 ]( m
NS:nodular sclerosis,结节硬化型 # _! \( n' R+ A3 [& N
Oncology:肿瘤学 $ [3 N$ e5 p3 A
Oto- :(前缀)耳的7 D; C2 F8 o' E# j9 ~3 i
PA:plasminogen activator,纤溶酶原激活物+ F! K! C/ s" W5 ]; F9 n
Packed red blood cells: 压积红细胞
& ^  q# H2 u- ~$ D9 Q9 y$ dPAE:post antibiotic effects,抗生素后续作用
- @6 ^2 [1 S6 \( z2 S  @3 k% e# ZPAI:plasminogen activator inhibitor,纤溶酶原激活物抑制剂
4 |9 g. `+ [2 D- F1 P5 ?* rPalliative:减轻的,缓解的
: e$ ]' a+ u0 N. d# |- \$ P- Wpalliative care unit (PCU):终末期病房,临终关怀病房
" s# [) O: p' x5 HPancytopenia:全血细胞减少症
4 b" M5 I- T& z+ G, D1 m  L-pathy:(后缀)病 0 k/ K  u' B% G
PB:peripheral blood, 外周血
. c0 d. `( i9 |; I6 U" kPBL:peripheral blood lymphocyte,外周血淋巴细胞
3 L" b; d" y8 a/ c9 i! yPBPC:peripheral blood progenitor cell,外周血祖细胞& r7 `# B6 o) P" k
PBSCT:peripheral blood stem cell transplantation,外周血干细胞移植4 S0 K! I6 F+ q$ ^! O8 Y3 Y% P
PCA:procoagulant activity,促凝活性物质" b. A7 c( m9 @, z
PCD:programmed cell death,细胞程序化死亡
1 m* `! [9 R3 r. h+ WPCL:plasma cell leukemia,浆细胞白血病1 D# {0 B' Y) J4 @5 i6 m
PCLI:plasma cell label index,浆细胞标记指数
' M! _) a/ L6 ^PCR:polymerase chain reaction, 多聚酶链反应6 S) W' Y* d3 m8 U. u+ J4 a& o* N5 X
PCR-RFLP: PCR-restriction fragment length polymorphisms,限制性片段长度多态性分析
. k" ~: O1 d  A* hPCR-SSOPH: PCR-sequence specific oligonucleotideprobe hybridization,序列特异性寡核苷酸探针杂交
4 a0 ?. T  ?# ^PDD:percentage depth dosage,百分深度剂量
1 c$ R' y0 t$ h# l8 a8 [PDGF:platelet derived growth factor,血小板衍生生长因子- X5 C1 B: M4 z9 q! R- u
PDR:primary drug resistance,原药耐药
0 R6 C6 |2 C' o* ^PE:plasma exchange,血浆置换2 Q0 s$ I, ^3 o; h( ~
-penia:(后缀)缺乏,不足   u0 N1 z+ o* w- V# Q
Peripheral neuropathy:周围神经病变 " B: Z. G6 w7 n1 N
Petechiae:瘀点,瘀斑
( r/ X3 A% }: a3 @% D  RPfu: plaque forming unit,空斑形成单位5 x' `* R: m1 ?% t, z0 D
PHA:phytahematoagglutinin,植物血凝素
, d$ X! K) ^; o% tPhlebitis:静脉炎 + ~4 b$ w1 {+ A9 {1 b2 w, e
PHSC:pluripotential hematopoietic stem cell,多能造血干细胞+ w$ O6 U, ?0 h* l, b) k
-plasia:(后缀)发展,形成
& P$ g# N# a* y( _Plasma:血浆6 v3 c$ g) b9 L  B( I
Plasma cell: 浆细胞 , Q: {* i7 M" ~( _
Platelet:血小板 " m0 {* S( r5 C5 k. e6 h! \
PLG:plasminogen,纤溶酶原( z8 H" T% @" o% i. e& |1 Y
PLL:prolymphocytic leukemia,幼淋巴细胞白血病
$ s5 w, I# P5 K7 Y* W7 DPLT:platelet,血小板
; x% I  m- b; P/ w9 k( y7 k& yPLT:primed lymphocyte test,预致敏淋巴细胞试验
2 C) x& g7 U) ?$ SPMN:polymorphonuclear leukocyte,多形核白细胞
7 X  [1 A# [' i' w+ T6 a2 D  zPNH:paroxysmal nocturnal hemoglobinuria,阵发性睡眠性血红蛋白尿÷
6 U/ {- c0 y4 K- yPNRE:p53 negative response element,p53阴性反应元件: N/ m9 A7 X; V/ ]  s2 k
POD:PML oncogenic domain,PML癌基因结构域
  R3 `' e# K" c. [2 W) [6 sPolycythemia:红细胞增多症
1 l6 l2 q" L; s# F0 aPositive selection:阳性选择7 U2 v7 @9 H: l* B3 O7 m0 g  {& [( Z
PPSC: pluripotent hemotopoietic stem cell,全能造血干细胞. e% o" u# g6 a  q( u  h
Preparative regimen:预处理方案
# h1 ^+ X& D- V# r3 a! |Progenitor:前体,祖先
! |0 H) l1 s. N$ Q0 D/ n% hPrognosis:预后 % w& r" ^  q; S; u6 z2 L
Prophylactic:adj.预防的;n. 预防性,预防药- ]" P! D5 H. E) J- s
Prophylaxis:预防法,预防& v1 L+ V4 o- y- \% `' c7 Z8 I# _
Protocol:草案,协议,治疗方案
3 i+ v$ y* k- d$ o0 j+ J$ P% aProto-onc: proto-oncogene,原癌基因
. B( M9 @# I$ Z' F1 j/ k8 BPSS:posterior superior spine,髂后上棘$ r' |) k8 n7 I5 B, o/ {
PT:prothrombin time,凝血酶原时间
' g" [& P& g' r, X6 jPTCL:peripheral T celll lymphoma,外周T细胞型淋巴瘤
2 y- L% u% ~- I' cPTH:post-transfusion hepatitis, 输血后肝炎
4 @! D) U" J: M. M' x# \3 _Pulmonary:肺的 8 [% Z, h4 W5 j/ [$ K; N1 h1 q
Purging:净化, v8 F4 f; G0 H/ L: D8 G) b: R
Purity:纯度( y/ E- m# H7 q' [+ t
PV:polycythemia vera,真性红细胞增多症' T3 M* p  x1 G$ o/ t
Quality of Life (QOL):生活质量
2 s, _! \4 A$ cRA:refractory anemia,难治性贫血   H& R/ O7 g: G. `* [
RAEB:refractory anemia with excessive blasts,难治性贫血伴原始细胞增多型/ ^7 k0 ?, m  v/ D: E  c/ z- [
RAEB-T:refractory anemia with excessive blasts,transformation,难治性贫血伴原始细胞增多转化型
) l+ U3 {0 p* L0 hRAR:retinoic acid receptor,维甲酸受体8 ]7 k1 l" \7 N7 T/ R, Z! ^  L
RAS:refractory anemia with sideroblasts,难治性贫血伴环状铁粒幼细胞增多2 s  D( U5 o0 Y/ X
RAS:retinoic acid syndrome,维甲酸综合征
8 q' h" i  i1 Q5 H9 mRB:retinoblastoma,视网膜母细胞瘤' m9 S( O5 t1 p* T( f  b
RBC: red blood cell,红细胞
- R" L5 j/ t' q) jReagent:试剂; `; ~4 e# n# G
Recipient:受者 2 |: i8 a4 r. o6 m4 ?9 X
Rejection:排斥
& h0 V7 n# r) j. n3 E, aRelapse:复发 ! A: B  Z5 _- A; C( d" @
Remission:缓解 9 G' S# O2 R; ], f+ }
Renal:肾脏的,肾的
- m7 Z+ V/ N: m  ~RFS:replase free survival,无复发生存
0 ~3 K, Z( L# ^1 i& a5 e  cRPC:radiation protective competence, 辐射保护能力
1 [. d* Q8 d  Q& DRegimen-related toxicity (RRT):预处理相关毒性) y! e. _' t( i( H& E. r, I
RT-PCR:reverse transcription polymerase chain reaction, 逆转录多聚酶链反应( J7 z+ D& K5 R2 b
SBB:sudan black B,苏丹黑B2 Z1 k5 t2 o6 V% O! f
SCE:sister chromatial exchange,姐妹染色单体交换- L4 v3 V! \+ X# f5 R6 K
SCF:stem cell factor,干细胞因子2 _  a; C. T. H3 q- x0 W. }
SCid:severe combined immunodeficiency disease,重症联合免疫缺陷
( E8 L3 y+ D, w2 [2 ]- X8 }" oSCL:stem cell leukemia,干细胞白血病
. }, C3 O  a1 X" m  {: dSE:specific estarase,特异性酯酶2 Z, @4 L" z& e+ E# }$ y
Selectin:选择素  D& w3 Z( V. p
Sense primer:同义引物
( x1 O& x3 z' w" x) G2 p; t1 [Separation:(细胞)分选
) U* l; _( U4 w( QSepsis:脓血病,败血病 % w$ d: D) T4 ^  }, b0 ~* E/ N% ^
Sequencing测序* G# D' U% E& H" b% F! V% y. Z
SF:serum ferritin,血清铁蛋白1 U! k7 ~& g% H- O1 B
SHML:sinus histocytosis with massive lymphadenopathy,窦性组织细胞增生症伴块状淋巴结肿大6 w2 b  I7 P' h# s# n5 z
SIA:stroma-support immunocytometric assay,基质支持免疫细胞流式细胞仪技术法
8 O6 u' Z+ X: Z5 p* |SLE:systemic lupus erythematosus,系统性红斑狼疮
. i/ Y6 C, J! Y! r% kSLL:small lymphocytic lymphoma,小淋巴细胞淋巴瘤
5 Q( Y! C% l* V' `0 l% p# MSolid tumor:实体瘤, V: R3 B8 R/ o. @7 x
SR-ALL:standard risk acute lymphocytic leukemia,标危型急性淋巴细胞白血病
5 V5 c( p, d, d& J5 E7 q/ O0 {SRC:SCid/NOD小鼠体内增殖的人造血干细胞,SCid造血重建细胞; d4 D5 _- K, J1 P% f
SS:Sezary syndrome,Sezary综合征
& P+ c7 r: ~/ p2 aStem cell:干细胞  i, A6 t% i6 |2 \, J) ?6 j1 p
STNI:subtotal nodal irradiation,次全淋巴结照射
- ]9 ]& O- q. t& T! lStomatitis:口炎
; w: b# c" e  CSubclavian catheter:锁骨下导管
' X" O9 l6 V1 q/ `" O# eSupernatant:上清6 h% E6 x* ]) r/ D' d7 i
Syn-BMT:Syngeneic bone marrow transplant:同基因骨髓移植
  |. ^: {  q8 s( `5 e9 BSyngeneic:同基因的- L/ R0 y- N, |% x
TAM:tumor associated macrophage,肿瘤相关巨噬细胞$ _1 ^2 D+ X* s- x% M
t-AML:treatment associated AML,治疗相关的急性髓性白血病' ^. @! c, @" N# }! j
TA-GVHD:transfusion associated graft-versus-host disease,输血相关的移植物抗宿主病
$ H5 `! a' R. m! TTAA:tumor associated antigen,肿瘤相关抗原/ d. }; [% [6 L1 a
TBGP:total blood granulocyte pool,总血液粒细胞池
% U0 w0 s; _5 [4 p5 Q- fTBI:total body irradiation,全身照射
  t1 }* o8 ]4 B! o8 r6 mTc:time of cell cycle, 细胞周期时间' _, Q7 M- {; c* b+ [* m
TCD:T cell depletion, T细胞去除
; p; p+ U9 a3 _8 {3 ]TCL:T cell leukemia/lymphoma,T细胞白血病/淋巴瘤 - B7 e; X8 X; ~: O
TCR:T cell receptor,T细胞受体2 ~3 }! L3 m# C9 _$ {* d/ H
TCS:tumor cell survival,肿瘤细胞成活4 u! ~  C- j3 e0 }3 U6 q
TEN:total enteral nutrition,完全胃肠内营养
; [& q* \& k) s6 p" k! N5 q! {! l8 w3 aTF:tissue factor,组织因子
. a& `- s$ e* Y; `* Q9 H4 T; {TF:thymic factor,胸腺因子; r0 p1 \: W3 U5 p) b' t6 N
TFPI:tissue factor pathway inhibitor,组织因子途径抑制物" k! I3 l7 }. M) a3 F/ c9 M
TGF:therapeutic gain factor,治疗获得系数7 w0 {% u" K3 \
TGF-β:transforming growth factor-β,转化生长因子β, x4 Z# }4 V' W& N( p
Thrombocyte:血小板 , ~) Y. t# H* i% P1 k9 X& A
Thrombocytopenia:血小板减少症2 j/ a# ^, N2 c. G$ l+ R
TIL:tumor infiltrate lymphocyte,肿瘤浸润淋巴细胞  F5 O% F1 {6 ^. w3 j( B
TL:testis leukemia睾丸白血病
/ X- H3 x0 @+ x& |4 @TLI:total Lymphoid irradiation,全淋巴照射$ n- e8 K+ v' L$ A6 m; i5 n8 Q6 J
Thrombotic microangiopathy (TMA):血栓性微血管病
3 }6 R- R* a0 Z$ B2 oTNF:tumor necrosis factor,肿瘤坏死因子
2 k! V( V! ?! T4 FTNI:total nodal irradiation,全淋巴结照射" N" o% Q, }% a) s0 G% `3 i
TOPO II:topoisomerase II,拓扑易构酶II
( O! |# s1 b" D, \6 Q3 GToxin:毒素 5 C$ l, ?/ v0 B/ J8 Y  u2 l' U5 M* l
Tpdt:potential doubling time,倍增时间- z+ l- N7 l/ a+ E3 d
T-PLL:T-prolymphocytic leukemia,T幼淋细胞白血病
4 T1 T- h3 i% p0 }! x; }TPN:total parenteral nutrition,全肠道外营养,静脉高营养. r6 c" M, ?) d* T# K
TPO:thrombopoietin,促血小板生成素" R" ?. l7 M3 ]
TPS:treatment planning system,治疗计划系统
% u  k/ h# K- s* g% {( D1 k) X2 CTranslocation:易位
, v/ Z5 B8 M! FTrauma:创伤
1 {: Y" y8 s* V# Y( ~TRM:transplantation related mortality,移植相关死亡率+ m/ T; Y" ?8 Y' e' l, ]5 C! G
TSC:timed-sequential chemotherapy,时相序贯化疗/ R5 `1 w3 \. u" c
TSPA:triophosphoramide,噻替派% g) n$ T6 z+ K5 [" D
TTP:thrombotic thrombocytopenic purpura,血栓性血小板减少性紫癜
1 X( C' E2 p9 [' ]$ uTumor:肿瘤 1 h; w6 A$ ?( D. r2 J
Tumor burden:肿瘤负荷 ) U" ~8 h5 K$ e
UCB:umbilical cord blood,脐带血
1 `' b6 n7 F6 i2 wUltrasound:超声
+ t; E+ D: a* N6 |( w) dUmbilical cord:脐带
" }" G  a& ]1 ?3 F! aVAHS:viral associated hemophagocytic syndrome,病毒相关嗜血细胞综合征
+ a, D. E4 T& Q- ], F$ }VGPR:very good partial remission,非常良好的部分缓解
  O6 g. t& ]9 R& s2 N% g9 RViability:活性$ ^& z/ `; V! @$ A
Virus:病毒
/ @# P, s9 E; s! ~8 K4 nVOD:veno-occlusive disease,静脉阻塞性疾病 / a5 u- q9 ^. P# \5 E1 Q# W
v-onc: virus oncogene,病毒癌基因/ p% G/ i. w: o, k: E8 L
VPF: vascular permeability factor,血管渗透因子
$ R' [5 P9 s" N- V3 }; L, @- UVZV:varicella zoster virus,水痘带状疱疹病毒
! a( S; O) |7 [- |: V. V# UWBC:white blood cell,白细胞 : d+ v4 C! W: ?7 Y) Q
Whole blood:全血
( J$ h0 b) a5 H9 WWT:Wilms tumor,肾母细胞瘤, T8 e6 X- {3 i2 ~7 i1 D
Xerostomia:口腔干燥症
9 W7 p# \: m8 A) x" AYield:产量




欢迎光临 干细胞之家 - 中国干细胞行业门户第一站 (http://www.stemcell8.cn/) Powered by Discuz! X1.5